極東製薬工業（株）

What 極東製薬工業（株） does

Kyokuto Pharmaceutical Industrial Co., Ltd. (極東製薬工業株式会社) is a privately held Japanese life-sciences company headquartered in Nihonbashi, Chuo-ku, Tokyo, operating across four product pillars: clinical diagnostics, food and environmental testing culture media, cell culture media and reagents, and antibody services. Its clinical diagnostics franchise is anchored by the GENECUBE fully automated genetic analysis system using QProbe nucleic acid detection chemistry (with results achievable in approximately 30 minutes for select assays such as MTB and MAI) and the Ribotest family of immunochromatographic kits, which are differentiated by proprietary monoclonal antibodies targeting the L7/L12 ribosomal protein of target bacteria such as Mycoplasma pneumoniae, Legionella, and Bordetella pertussis. The company also markets a broad Brothmic series for mycobacterial drug susceptibility testing, a Ranpia clinical chemistry reagent line, and the Insepack II vacuum blood collection tube line.

The company's cell culture business targets both regenerative medicine research and recombinant protein production, offering GMP-manufactured cryopreservation solutions (CP-1 High Grade and CP-5E), E-RDF hybridoma media, and CHO/HEK293 transient expression media (CHO TGE Medium, KP293 type1/type2 Expression Medium), supported by a custom media manufacturing service. The antibody business is built around a 2019 exclusive Japan distribution partnership with US-based Abwiz Bio Inc., through which Kyokuto provides the RabWiz rabbit monoclonal antibody development platform (leveraging US Patent 9,890,414 WizAmp technology that achieves picomolar KD affinity) and a catalog of research-use rabbit monoclonal antibody products.

Kyokuto generates revenue primarily through direct B2B sales of one-time-purchase unit-priced diagnostic reagents, culture media, cell culture products, and custom antibody services to clinical laboratories, hospitals, research institutions, and food/pharmaceutical testing customers in Japan. Distribution is handled through a direct sales model with branch offices, complemented by product inquiry forms, academic conference presence (Japan Electrophoresis Society, Japan Antibody Society, Regenerative Medicine JAPAN), on-demand webinars, and control survey (proficiency testing) services. Pricing is publicly disclosed across the catalog with per-unit prices ranging from approximately ¥1,300 to ¥650,000. No public listing, funding events, or revenue figures are disclosed in the source material.

Name

極東製薬工業（株）

Legal name

極東製薬工業株式会社

Website

https://kyokutoseiyaku.co.jp

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Kyokuto Pharmaceutical Industrial (極東製薬工業) is a privately held Japanese specialty life-sciences company that sells 670+ clinical diagnostic reagents (including the GENECUBE genetic analyzer and Ribotest immunochromatographic kits), food and environmental testing culture media, cell culture media for regenerative medicine and biologics, and rabbit monoclonal antibody services via its exclusive Japan partnership with Abwiz Bio.

Ownership category

akta.pro rank

Headquarters

HQ city

中央区, 東京都

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Diagnostic Reagent and Test Kit Sales: Sale of clinical diagnostic reagents including immunochromatographic test kits (Ribotest, ImunoArrow, Capilia), microbiological culture media, and genetic analysis reagents for the GENECUBE system.
2. Cell Culture Media and Reagent Sales: Sale of cell culture media, freeze-preservation solutions (CP-1 High Grade, CP-5E), and cell-related reagents for regenerative medicine and research applications.
3. Custom Antibody Development Services: Custom rabbit monoclonal antibody development, affinity maturation, and antibody engineering services provided in partnership with Abwiz Bio Inc.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

No source-backed description available; the input did not contain resolvable source material describing the company's offerings.

Product overview

極東製薬工業株式会社（KYOKUTO PHARMACEUTICAL INDUSTRIAL CO., LTD）は、生命科学領域における微生物検査・培養試薬、臨床診断用体外診断用医薬品、細胞培養関連製品、抗体サービスの4本を柱とする製品群を提供する日本在京の製薬・試薬メーカーです。主力製品として、GENECUBE（全自動遺伝子解析装置）とその専用試薬群、リボテストシリーズ（イムノクロマトキット）、ブロスミックシリーズ（抗酸菌薬剤感受性検査キット）、培地シリーズ（バイタルメディア、プレメディア）を展開しています。細胞培養分野ではCHO細胞・293細胞用の発現培地や凍結保存液（CP-1 High Grade）、抗体サービスではAbwiz Bio社との提携によるウサギモノクローナル抗体作製サービス（RabWizテクノロジー）を展開しています。

Differentiator

Problem solved

Functional benefit

Brands

• Abwiz Bio: Rabbit monoclonal antibody products developed by US-based Abwiz Bio Inc., distributed in Japan by Kyokuto Pharmaceutical. Products include SARS-CoV-2 antibodies, PLXDC2 antibodies, Myl9/12 antibodies, and others. The partnership began in September 2019 as an exclusive domestic sales agreement.
• リボテスト
• ジーンキューブ
• インセパック
• バイタルメディア
• プレメディア
• ブロスミック
• ランピア

Quantifiable outcome

• GENECUBE achieves results in approximately 30 minutes from sample to detection for certain assays (e.g., MTB, MAI)
• +1 more outcomes

Segments3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Abwiz Bio Inc.coreTechnology or Integration · 9 September 2019Kyokuto Pharmaceutical entered an exclusive distribution agreement with Abwiz Bio Inc. (California, USA) for innovative antibody development and antibody engineering services in Japan. Kyokuto serves as the exclusive domestic distributor for Abwiz Bio's rabbit monoclonal antibody products, custom antibody development services, and affinity maturation services. Abwiz Bio provides the RabWiz technology platform for high-affinity rabbit monoclonal antibody development using proprietary WizAmp technology.
• Japan Pharmaceutical Manufacturers Association (日本製薬団体連合会)minorOthersKyokuto Pharmaceutical is a member company of the Japan Pharmaceutical Manufacturers Association (FPMaj), a certified personal information protection organization designated by the Minister of Health, Labour and Welfare. The company participates in this association for personal information protection compliance purposes.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• bioMérieux: Global microbiology diagnostics company with significant Japan presence, specializing in culture media, immunoassays, and molecular microbiology. Closest global incumbent peer for Kyokuto's microbiology and culture media franchise.
• Sysmex Corporation: Major Japanese diagnostics company with a much broader portfolio spanning hematology, clinical chemistry, immunoassay, and life science research. Competes with Kyokuto across multiple reagent categories but at substantially greater scale.
• Beckman Coulter: Global diagnostics and life science research company (Danaher) with clinical chemistry, immunoassay, and cell biology product lines. Overlaps with Kyokuto's clinical chemistry reagents and cell culture media.
• H.U. Group Holdings, Inc. Major Japanese clinical testing services and in-vitro diagnostics provider. Operates SRL, Japan's leading clinical reference lab, and BML — directly relevant downstream customer and adjacent competitor to Kyokuto's diagnostics reagent business.
• Roche Diagnostics K.K. Global diagnostics leader's Japan operations covering clinical chemistry, immunoassays, and molecular diagnostics (including the cobas Liat PCR platform). Competes with GENECUBE in Japanese clinical labs.

Direct peers

• Tauns Laboratories, Inc. Japanese in-vitro diagnostics company specializing in infectious disease test kits and clinical reagents, with a similar specialty focus and domestic distribution model to Kyokuto.
• Denka Company Limited: Japanese chemicals and diagnostics company with genetic testing, clinical reagent, and life science offerings. Overlaps with Kyokuto in molecular diagnostics and specialty life science reagents.
• Eiken Chemical Co., Ltd. Japanese in-vitro diagnostics company with overlapping focus on clinical reagents, immunological tests, and infectious disease diagnostics. Eiken's fecal occult blood and immune reagent portfolio serves the same Japanese clinical lab customers as Kyokuto.
• Jokoh Co., Ltd. Japanese clinical chemistry and immunology diagnostics company with a similar reagent-based portfolio and domestic distribution model. Closely comparable in scale and customer focus.
• Nissui Pharmaceutical Co., Ltd. Japanese microbiology diagnostics and culture media manufacturer with directly overlapping product lines in clinical, food, and environmental microbial testing. A particularly close peer given culture media portfolio similarity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E6%A5%B5%E6%9D%B1%E8%A3%BD%E8%96%AC%E5%B7%A5%E6%A5%AD%EF%BC%88%E6%A0%AA%EF%BC%89

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 極東製薬工業（株）